Ab&B Bio-Tech CO., LTD. JS (HKG:2627)
Hong Kong
· Delayed Price · Currency is HKD
40.42
-0.30 (-0.74%)
At close: Dec 5, 2025
HKG:2627 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Revenue | 323.76 | 259.61 | 52.17 |
| Revenue Growth (YoY) | - | 397.65% | - |
| Cost of Revenue | 105.9 | 108.16 | 72.51 |
| Gross Profit | 217.86 | 151.46 | -20.34 |
| Selling, General & Admin | 216.45 | 199.81 | 132.39 |
| Research & Development | 203.96 | 204.62 | 280.86 |
| Other Operating Expenses | 0.11 | 2.97 | - |
| Operating Expenses | 420.55 | 407.47 | 413.3 |
| Operating Income | -202.7 | -256.01 | -433.65 |
| Interest Expense | -20.23 | -17.71 | -6.61 |
| Interest & Investment Income | 0.24 | 0.47 | 3.16 |
| Other Non Operating Income (Expenses) | -6.34 | 15.35 | 11.04 |
| EBT Excluding Unusual Items | -229.03 | -257.9 | -426.05 |
| Gain (Loss) on Sale of Investments | 0.01 | 0.24 | 1.35 |
| Gain (Loss) on Sale of Assets | -0.88 | -1.06 | -0.04 |
| Pretax Income | -224.43 | -258.72 | -424.74 |
| Net Income | -224.43 | -258.72 | -424.74 |
| Net Income to Common | -224.43 | -258.72 | -424.74 |
| Shares Outstanding (Basic) | 360 | 360 | 360 |
| Shares Outstanding (Diluted) | 360 | 360 | 360 |
| EPS (Basic) | -0.62 | -0.72 | -1.18 |
| EPS (Diluted) | -0.62 | -0.72 | -1.18 |
| Free Cash Flow | -229.07 | -399.08 | -571.29 |
| Free Cash Flow Per Share | -0.64 | -1.11 | -1.59 |
| Gross Margin | 67.29% | 58.34% | -39.00% |
| Operating Margin | -62.61% | -98.61% | -831.25% |
| Profit Margin | -69.32% | -99.66% | -814.18% |
| Free Cash Flow Margin | -70.75% | -153.72% | -1095.09% |
| EBITDA | -145.92 | -206.54 | -394.1 |
| EBITDA Margin | -45.07% | -79.56% | - |
| D&A For EBITDA | 56.78 | 49.47 | 39.54 |
| EBIT | -202.7 | -256.01 | -433.65 |
| EBIT Margin | -62.61% | -98.61% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.